| |
|
|
| Name: |
MPM ONCOLOGY IMPACT MANAGEMENT LP |
| City: |
CAMBRIDGE |
| State: |
MA |
| Zip: |
02142 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
43 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CGEM |
Cullinan Oncology Ord Shs |
1 |
- |
$0.00 |
$130,326,000 |
7,648,268 |
20.95% |
52,390,000 |
0 |
17.574 |
N/A |
|
|
GERN |
Geron Corporation |
2 |
- |
$3.66 |
$34,570,000 |
10,475,675 |
5.56% |
11,960,000 |
-239,945 |
1.929 |
Drug Manufacturers - ... |
|
|
IOVA |
Iovance Biotherapeutics Inc |
3 |
- |
$10.33 |
$32,604,000 |
2,200,000 |
5.24% |
5,861,000 |
-1,089,470 |
1.029 |
N/A |
|
|
ZNTL |
Zentalis Pharmaceuticals, Llc |
4 |
New |
$0.00 |
$23,895,000 |
1,516,183 |
3.84% |
23,895,000 |
1,516,183 |
1.785 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
5 |
- |
$0.00 |
$23,815,000 |
1,745,943 |
3.83% |
4,697,000 |
0 |
4.599 |
N/A |
|
|
STRO |
Sutro Biopharma Inc |
6 |
New |
$4.26 |
$23,146,000 |
4,096,619 |
3.72% |
23,146,000 |
4,096,619 |
7.277 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
7 |
- |
$50.54 |
$22,496,000 |
480,588 |
3.62% |
5,480,000 |
2,354 |
0.654 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
8 |
- |
$0.00 |
$22,116,000 |
1,953,690 |
3.56% |
-3,940,000 |
96,554 |
3.545 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
9 |
- |
$235.06 |
$16,396,000 |
61,399 |
2.64% |
6,930,000 |
20,489 |
0.311 |
Diagnostic Substances |
|
|
NTRA |
Natera, Inc. |
10 |
New |
$108.51 |
$15,769,000 |
172,413 |
2.54% |
15,769,000 |
172,413 |
0.15 |
N/A |
|
|
HOWL |
Werewolf Therapeutics, Inc. |
11 |
- |
$0.00 |
$15,474,000 |
2,388,011 |
2.49% |
6,256,000 |
0 |
5.873 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
12 |
- |
$0.00 |
$14,871,000 |
296,050 |
2.39% |
-2,918,000 |
1,474 |
0.494 |
N/A |
|
|
AVDL |
AVADEL Pharmaceuticals Plc |
13 |
- |
$15.99 |
$14,714,000 |
871,149 |
2.37% |
5,324,000 |
206,163 |
1.496 |
Drug Delivery |
|
|
INSM |
Insmed Inc |
14 |
- |
$24.16 |
$14,400,000 |
530,794 |
2.32% |
-1,967,000 |
2,644 |
0.35 |
Biotechnology |
|
|
ALXO |
Alx Oncology Holdings Inc |
15 |
- |
$0.00 |
$14,143,000 |
1,268,471 |
2.27% |
-4,689,000 |
3,712 |
2.546 |
N/A |
|
|
VKTX |
Viking Therapeutics, Inc. |
16 |
- |
$63.01 |
$12,300,000 |
150,000 |
1.98% |
6,246,000 |
-175,284 |
0.149 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
17 |
- |
$25.97 |
$11,901,000 |
432,598 |
1.91% |
236,000 |
50,000 |
0.483 |
N/A |
|
|
RGNX |
Regenxbio Inc. |
18 |
- |
$15.47 |
$11,569,000 |
549,078 |
1.86% |
1,713,000 |
0 |
1.248 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
19 |
New |
$41.08 |
$11,467,000 |
245,590 |
1.84% |
11,467,000 |
245,590 |
0.299 |
Restaurants |
|
|
MORF |
Morphic Holding, Inc. |
20 |
- |
$29.26 |
$11,452,000 |
325,333 |
1.84% |
2,102,000 |
1,591 |
0.654 |
N/A |
|
|
ETNB |
89bio, Inc. |
21 |
New |
$8.93 |
$11,265,000 |
967,742 |
1.81% |
11,265,000 |
967,742 |
0.989 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
22 |
- |
$12.70 |
$10,751,000 |
614,010 |
1.73% |
8,573,000 |
514,010 |
0.979 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
23 |
New |
$0.00 |
$10,734,000 |
1,137,108 |
1.73% |
10,734,000 |
1,137,108 |
1.804 |
N/A |
|
|
XERS |
Xeris Pharmaceuticals Inc |
24 |
- |
$2.01 |
$9,208,000 |
4,166,496 |
1.48% |
167,000 |
319,264 |
3.074 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
25 |
- |
$76.79 |
$9,107,000 |
114,127 |
1.46% |
1,674,000 |
20,740 |
0.241 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
26 |
- |
$11.69 |
$9,022,000 |
760,722 |
1.45% |
9,022,000 |
760,722 |
2.001 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
27 |
- |
$39.77 |
$8,806,000 |
273,217 |
1.42% |
965,000 |
-191 |
0.167 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
28 |
- |
$0.00 |
$8,475,000 |
638,163 |
1.36% |
-421,000 |
0 |
0.794 |
N/A |
|
|
FOLD |
Amicus Therapeutics Inc |
29 |
- |
$10.61 |
$8,469,000 |
718,970 |
1.36% |
-1,689,000 |
3,087 |
0.211 |
Biotechnology |
|
|
AKRO |
Akero Therapeutics, Inc. |
30 |
New |
$0.00 |
$8,410,000 |
332,924 |
1.35% |
8,410,000 |
332,924 |
0.543 |
N/A |
|
|
ADAP |
Adaptimmune Therapeutics PLC |
31 |
- |
$1.05 |
$8,052,000 |
5,095,912 |
1.29% |
4,011,000 |
0 |
3.295 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
32 |
New |
$0.00 |
$8,049,000 |
441,259 |
1.29% |
8,049,000 |
441,259 |
0.478 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
33 |
- |
$0.00 |
$7,724,000 |
1,639,849 |
1.24% |
-4,247,000 |
0 |
4.462 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
34 |
- |
$7.53 |
$6,906,000 |
832,017 |
1.11% |
-2,255,000 |
0 |
0.615 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
35 |
- |
$33.17 |
$6,897,000 |
110,779 |
1.11% |
4,009,000 |
60,779 |
0.459 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
36 |
New |
$0.00 |
$4,626,000 |
1,340,960 |
0.74% |
4,626,000 |
1,340,960 |
2.238 |
N/A |
|
|
CMPX |
Compass Therapeutics Ord Shs |
37 |
New |
$0.00 |
$3,903,000 |
1,971,402 |
0.63% |
3,903,000 |
1,971,402 |
2.011 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
40 |
Closed |
$0.00 |
$0 |
0 |
0% |
-639,000 |
-70,000 |
0 |
N/A |
|
|
HARP |
Harpoon Therapeutics, Inc. |
41 |
Closed |
$0.89 |
$0 |
0 |
0% |
-3,635,000 |
-319,670 |
0 |
N/A |
|
|
INZY |
Inozyme Pharma, Inc. |
39 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,379,000 |
-323,813 |
0 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
43 |
Closed |
$32.48 |
$0 |
0 |
0% |
-14,436,000 |
-611,181 |
0 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
38 |
Closed |
$36.38 |
$0 |
0 |
0% |
-9,403,000 |
-230,696 |
0 |
N/A |
|
|
KRTX |
Karuna Therapeutics, Inc. |
42 |
Closed |
$0.00 |
$0 |
0 |
0% |
-16,863,000 |
-53,279 |
0 |
N/A |
|
